| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bba0a34651fd8cd73cf83e6a9effe12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2015-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3b836e9d9d0388c2ce0a4b13cf19b59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a76128d0c2024a3166fa9add6af1ccc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_437b61ba388c06a47c2c2c4e946044e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3036bca93bb7f84c446413dda9b3fb83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3098fc3632ef8c66f5705c0a2219ffd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae532dfc089a40bd1a2f05bb45cdc1f3 |
| publicationDate |
2020-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2777550-T3 |
| titleOfInvention |
Roflumilast prodrug |
| abstract |
A compound represented by formula (I) or a pharmaceutically acceptable salt thereof: ** (See formula) ** where R is a C1-6 alkyl group optionally substituted with one or more hydroxyl groups, a C1-6 alkoxy group or a cyano group. |
| priorityDate |
2014-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |